Home

Thursday, May 24, 2018 - 13:52
The ingredients and science behind growth factor-based topicals.By Inga HansenGrowth factor-BASED serums and creams have become ubiquitous in topical antiaging skin care. But what these different products contain can vary widely. Some products contain actual growth factors—either animal- or plant-derived—and others use so-called “signaling” ingredients, typically peptides that trigger the cells in a manner similar to naturally occurring growth factors. In all cases, the goal is to combat the changes that occur in aging skin
https://www.medestheticsmag.com/restoring-growth
Thursday, May 24, 2018 - 13:52
The ingredients and science behind growth factor-based topicals.By Inga HansenGrowth factor-BASED serums and creams have become ubiquitous in topical antiaging skin care. But what these different products contain can vary widely. Some products contain actual growth factors—either animal- or plant-derived—and others use so-called “signaling” ingredients, typically peptides that trigger the cells in a manner similar to naturally occurring growth factors. In all cases, the goal is to combat the changes that occur in aging skin
https://www.medestheticsmag.com/restoring-growth
Thursday, May 24, 2018 - 13:36
The U.S. Food and Drug Administration (FDA) has approved the hyaluronic acid (HA) dermal filler Restylane Lyft (Nestlé Skin Health) for the correction of age-related volume loss in the back of the hands for patients over the age of 21. It is the first HA injectable gel to be FDA-approved for restoring fullness to the back of the hands.
https://www.medestheticsmag.com/restylane-lyft-approved-hands

Advertisement - Box 1

Advertisement - Box 2

Thursday, May 24, 2018 - 13:36
The U.S. Food and Drug Administration (FDA) has approved the hyaluronic acid (HA) dermal filler Restylane Lyft (Nestlé Skin Health) for the correction of age-related volume loss in the back of the hands for patients over the age of 21. It is the first HA injectable gel to be FDA-approved for restoring fullness to the back of the hands.
https://www.medestheticsmag.com/restylane-lyft-approved-hands
Thursday, May 24, 2018 - 13:32
Revance Therapeutics has established four new positions at the company as it prepares for the launch and commercialization of its daxibotulinumtoxinA injectable (RT002) for the treatment of glabellar lines.
https://www.medestheticsmag.com/revance-gears-launch-rt002-neurotoxin
Thursday, May 24, 2018 - 13:32
Revance Therapeutics has established four new positions at the company as it prepares for the launch and commercialization of its daxibotulinumtoxinA injectable (RT002) for the treatment of glabellar lines.
https://www.medestheticsmag.com/revance-gears-launch-rt002-neurotoxin

Advertisement - Box 3

Advertisement - Box 4

Thursday, May 10, 2018 - 13:00
Aesthetic physicians rightly focus on delivering optimal outcomes, but consistently good cosmetic results may not be enough to maintain positive online reviews. A special topic paper in the May 2018 issue of Plastic and Reconstructive Surgery revealed that nearly 40 percent of negative online reviews were written by people who did not undergo a procedure.
https://www.medestheticsmag.com/close-half-negative-reviews-not-related-outcomes
Thursday, May 10, 2018 - 12:57
eRelevance Corporation, a company that provides patient engagement technologies and services for medical practices, has launched a new service called “Response Follow-up” to help practices follow up with prospective patients who have reached out to their offices in response to promotions and marketing campaigns. The service combines phone, email and text follow-up.
https://www.medestheticsmag.com/new-tool-streamline-patient-follow
Thursday, May 10, 2018 - 12:57
eRelevance Corporation, a company that provides patient engagement technologies and services for medical practices, has launched a new service called “Response Follow-up” to help practices follow up with prospective patients who have reached out to their offices in response to promotions and marketing campaigns. The service combines phone, email and text follow-up.
https://www.medestheticsmag.com/new-tool-streamline-patient-follow

Pages

Advertisement - Box 5

Advertisement - Box 6